# SAM #6912710440008

Award for Novartis Pluvicto and Lutathera cancer-treatment radiopharmaceuticals

**Buyer:** VA 262 Network Contract Office 22
**Posted:** October 29, 2026
**Identifier:** 6912710440008
**NAICS:** 325412, 424210

The Department of Veterans Affairs awarded a one-month bridge order for cancer-treatment radiopharmaceuticals for VA Greater Los Angeles Healthcare System.
- **Government buyer:** Department of Veterans Affairs, VA Greater Los Angeles Healthcare System, Network Contracting Office 22.
- **Awarded vendor and OEM:** **Novartis Pharmaceuticals Corporation**, the named manufacturer and source of the requested medicines.
- **Products:** Pluvicto and Lutathera radiopharmaceuticals. Quantities and part numbers are not specified.
- **Purpose and requirements:** Maintain continuity of cancer care while the longer-term order is finalized. The justification cites urgent patient-care needs, the specialized and proprietary nature of the medicines, and Novartis as the only authorized source listed in the VA NAC catalog.
- **Award amount:** $769,496.80.
- **Period of performance:** Projected one-month bridge period; specific calendar dates are not included here.

[View original listing](https://sam.gov/opp/a66454bd1ce2492c8507a01cd86fa69e/view)